Хайлтын үр дүнгүүд - Aditya Mehta
- 4-н 1 - 4 үр дүнгүүдийг харуулж байна
-
1
Dapagliflozin as Additional Treatment to Liraglutide and Insulin in Patients With Type 1 Diabetes -н Nitesh Kuhadiya, Husam Ghanim, Aditya Mehta, Manisha Garg, Salman Khan, Jeanne Hejna, Barrett Torre, Antoine Makdissi, Ajay Chaudhuri, Manav Batra, Paresh Dandona
Хэвлэсэн 2016Artigo -
2
Comparative Metagenome-Assembled Genome Analysis of “Candidatus Lachnocurva vaginae”, Formerly Known as Bacterial Vaginosis-Associated Bacterium−1 (BVAB1) -н Johanna B. Holm, Michael France, Bing Ma, Elias McComb, Courtney K. Robinson, Aditya Mehta, Luke J. Tallon, Rebecca M. Brotman, Jacques Ravel
Хэвлэсэн 2020Artigo -
3
Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks -н Nitesh Kuhadiya, Sandeep Dhindsa, Husam Ghanim, Aditya Mehta, Antoine Makdissi, Manav Batra, Sartaj Sandhu, Jeanne Hejna, Kelly Green, Natalie Bellini, Min Yang, Ajay Chaudhuri, Paresh Dandona
Хэвлэсэн 2016Artigo -
4
Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia -н Vivek Kumar, Sikander Ailawadhi, Leyla Bojanini, Aditya Mehta, Suman Biswas, Taimur Sher, Vivek Roy, Prakash Vishnu, Julian A. Marin‐Acevedo, Victoria R. Alegria, Aneel Paulus, Sonikpreet Aulakh, Madiha Iqbal, Rami Manochakian, Winston Tan, Asher Chanan‐Khan, Meghna Ailawadhi
Хэвлэсэн 2019Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Internal medicine
Medicine
Diabetes mellitus
Endocrinology
Insulin
Liraglutide
Type 2 diabetes
16S ribosomal RNA
Alternative medicine
Bacteria
Bacterial vaginosis
Biology
Cancer
Candidatus
Chronic lymphocytic leukemia
Clinical trial
Confidence interval
Dapagliflozin
Environmental health
Epidemiology
Gene
Genetics
Hazard ratio
Incidence (geometry)
Leukemia
Metagenomics
Microbiology
Multivariate analysis
Oncology
Optics